Boston's strategy for combatting drug use a ‘terrible policy’: Bill Bennett Fox News contributor Bill Bennett slams Boston’s ‘harm reduction’ strategy giving pipes to drug users and weighs in on schools stocking up on narcan as fentanyl overdoses rise.
Bullies in white coats? 'Too many' health care workers experience toxic workplaces, studies show Doctors, nurses and others may be trained to treat patients with compassion and respect, but too many are treating each other — meaning their colleagues — with disrespect, studies have found.
Democrats push firearms purchasing ban for people who voluntarily give up their 2A rights House Democrats advanced a bill that would set up a federal register of people who agree not to buy guns, an idea aimed at curbing gun suicides by the mentally ill.
Hilary Duff discusses 'horrifying' eating disorder as 17-year-old child star Nearly 20 years after suffering from an eating disorder, 35-year-old Hilary Duff is learning to appreciate her body's health.
Alabama Medicaid program to end sobriety mandate on hepatitis treatment Alabama's Medicaid program to end the sobriety mandate on people getting hepatitis treatment has reached a settlement. This allows those with drug abuse issues to seek treatment.
Sen. Cory Booker leads last-minute push for cocaine sentencing reform Sen. Cory Booker of New Jersey is taking a lead role in pushing for federal drug sentencing reform to even out penalties for cocaine-related offenses regardless of form.
MN school district accepts $1.1 million grant for controversial outreach program The Faribault, Minnesota, school district voted Monday to accept $1.1 million in state aid for an anti-drug program that some call discriminatory against white students.
COVID-19 pandemic took a toll on teenage mental health, causing more stress, anxiousness, aging brains Drs. Paul and Nicole Saphier join 'Fox & Friends Weekend' to discuss the impact COVID-19 had on the mental health of teenagers and the development of a fentanyl vaccine to help combat the fentanyl crisis.
Alzheimer's experimental drug may slow progression of disease, but there are risks: experts A study just published in the New England Journal of Medicine indicates that the experimental drug lecanemab showed a slowing of cognitive decline progression by 27% in those with early Alzheimer's.
10 middle school students in Los Angeles appear to have overdosed on marijuana edibles Ten middle school students, between the ages of 12 and 15, may have overdosed on cannabis edibles in Los Angeles, California. Some of the children were then taken to medical centers.
